Since recruitment of DNMT3A by the pmx‐1b isoform of PRRX1 leads to GIC differentiation through the epigenetic regulation of PROM1 gene expression, pmx‐1b and DNMT3A are potentially interesting targets for the treatment of glioblastoma. This evidence concerns the gene DNMT3A and glioblastoma.